Get started
Author

Yingxing Zhou

Observed institution: Hubei Polytechnic University
ORCID: 0009-0003-7677-0570
Observed ORCID: 0009-0003-7677-0570
OpenAlex ID: A5075580383
HDAC-targeting epigenetic modulators for cancer immunotherapy
2024 · Binbin Cheng, Wei Pan, et al. · European Journal of Medicinal Chemistry · 119
Recent progress in the development of hypoxia-inducible factor 2α (HIF-2α) modulators: Inhibitors, agonists, and degraders (2009–2024)
2024 · Binbin Cheng, Xianshi Ma, et al. · European Journal of Medicinal Chemistry · 18
Research progress in DNA damage response (DDR)-targeting modulators: From hits to clinical candidates
2025 · Binbin Cheng, Zongbao Ding, et al. · European Journal of Medicinal Chemistry · 17
Research Progress in Targeting GSPT1: Molecular Glues, Bifunctional Degraders, and Antibody-Enabled Molecular Glues for Cancer Therapy
2025 · Binbin Cheng, Yaping Wang, et al. · Journal of Medicinal Chemistry · 12
Research progress in bifunctional small molecules for cancer immunotherapy
2025 · Binbin Cheng, Hongqiao Li, et al. · European Journal of Medicinal Chemistry · 11
Discovery of Novel Heterotricyclic Compounds as DNA-Dependent Protein Kinase (DNA-PK) Inhibitors with Enhanced Chemosensitivity, Oral Bioavailability, and the Ability to Potentiate Cancer Immunotherapy
2024 · Binbin Cheng, Yaru Shi, et al. · Journal of Medicinal Chemistry · 8
Correction to: 15-Membered Macrocyclic Schiff-Base-Pd(0) Complex Immobilized on Fe3O4 MNPs: An Novel Nanomagnetic Catalyst for the One-Pot Three-Component C–H Chalcogenation of Azoles by S8 and Aryl Iodides
2023 · Jin Liu, Shaofen Jin, et al. · Catalysis Letters
PDF
Works count: 7
Citation count: 185
H-index: 6
I10-index: 5
Year
Topic
Type